Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18673137 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL18657388 | 0.82 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL22292169 | 0.82 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL18636925 | 0.81 | — | — | |
| SCHEMBL259454 | 0.80 | LMNA (0.30) | — | |
| SCHEMBL7806928 | 0.80 | LMNA (0.30) | — | |
| SCHEMBL14816929 | 0.79 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL16186296 | 0.78 | — | — | |
| SCHEMBL28773027 | 0.78 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL15177581 | 0.78 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230235300-A1 | Transaminase Mutant And Use Thereof | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2023-07-27 | — | — | US | disclosed |
| US-20230215723-A1 | METHODS OF MANUFACTURING INTEGRATED CIRCUIT DEVICES USING CARBONYL COMPOUNDS | ADEKA CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20210107853-A1 | SYNTHESIS OF MONO-CHLORINATED ACETOPHENONE | SIEGFRIED AG (CH) | 2021-04-15 | — | — | US | disclosed |
| EP-3505558-B1 | PROCESS FOR PREPARING A POLY(AMIDE-IMIDE) FILM AND A POLY(AMIDE-IMIDE) FILM PREPARED BY THE SAME | SKC CO LTD (KR) | 2020-07-15 | — | — | EP | disclosed |
| US-9956191-B2 | Composition of 5-nitrobenzoate derivatives as anti-metastatic agent that inhibits tumor cell-induced platelet aggregation | UNIV CHANG GUNG (TW) | 2018-05-01 | — | — | US | disclosed |
| WO-2017192595-A1 | RECONFIGURABLE MULTI-STEP CHEMICAL SYNTHESIS SYSTEM AND RELATED COMPONENTS AND METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-11-09 | — | — | WO | disclosed |
| US-20170172949-A1 | COMPOSITION OF 5-NITROBENZOATE DERIVATIVES AS ANTI-METASTATIC AGENT THAT INHIBITS TUMOR CELL-INDUCED PLATELET AGGREGATION | CHANG GUNG UNIVERSITY (TW) | 2017-06-22 | — | — | US | disclosed |
| US-9499494-B2 | Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150203456-A1 | PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | CAMBRIA PHARMACEUTICALS DISTRIBUTING TRUST | 2015-07-23 | — | — | US | disclosed |
| EP-2402300-A1 | Hydroxyl compounds and compositions for cholesterol management and related uses | Esperion Therapeutics Inc. (US) | 2012-01-04 | — | — | EP | disclosed |
| EP-1954668-B1 | HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2011-09-28 | — | — | EP | disclosed |
| EP-1833815-B1 | A PROCESS FOR PREPARATION OF IMATINIB BASE | INST FARMACEUTYCZNY (PL) | 2010-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203456-A1 | PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | NUDT1, TYMP, HPRT1 | ALDH1A1 3417/4885 |
| US-20170172949-A1 | COMPOSITION OF 5-NITROBENZOATE DERIVATIVES AS ANTI-METASTATIC AGENT THAT INHIBITS TUMOR CELL-INDUCED PLATELET AGGREGATION | PTAFR, PF4, F11 | ALDH1A1 881/4885 |
| US-20210107853-A1 | SYNTHESIS OF MONO-CHLORINATED ACETOPHENONE | ACACA, CYP51A1, ACACB | ALDH1A1 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.